Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Lithium].

A Sparsa1, J-M Bonnetblanc

  • 1Service de Dermatologie, CHRU Dupuytren, 2, avenue Martin Luther King, 87042 Limoges Cedex.

Annales De Dermatologie Et De Venereologie
|April 27, 2004
PubMed
Summary
This summary is machine-generated.

Topical lithium, particularly lithium gluconate, shows efficacy in treating seborrheic dermatitis and herpes simplex, with good local safety and fewer side effects than oral lithium.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Simulation training for urinary drainage improves skill retention].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2015
Same author

Use of bosentan for digital ulcers related to systemic sclerosis: a real-life retrospective French study of 89 patients treated since specific approval.

Scandinavian journal of rheumatology·2014
Same author

[Assessment of tele-expertise among elderly subjects in retirement homes].

Annales de dermatologie et de venereologie·2013
Same author

Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial.

The British journal of dermatology·2012
Same author

[Historic malignant tumour: 27 observations].

Annales de dermatologie et de venereologie·2012
Same author

[Photodynamic therapy for the treatment of extramammary Paget's disease].

Annales de dermatologie et de venereologie·2012
Same journal

2024 guidelines (S3) for the therapeutic management of patients with genital herpes.

Annales de dermatologie et de venereologie·2026
Same journal

Topical JAK inhibitors in the lichen planus spectrum: a systematic review.

Annales de dermatologie et de venereologie·2026
Same journal

2024 recommendations for the therapeutic management of anogenital warts.

Annales de dermatologie et de venereologie·2026
Same journal

Successful use of thalidomide in treating metastatic Crohn's disease.

Annales de dermatologie et de venereologie·2026
Same journal

Multiple cutaneous juvenile xanthogranuloma: a monocentric study.

Annales de dermatologie et de venereologie·2026
Same journal

Cartilage-hair-hypoplasia associated with granulomatosis induced by rubella vaccine.

Annales de dermatologie et de venereologie·2026
See all related articles

Area of Science:

  • Dermatology
  • Pharmacology
  • Biochemistry

Context:

  • Lithium, a cation, is utilized topically in dermatology, though its precise mechanism of action remains unclear.
  • Its enzymatic inhibitory actions include Na/K ATPase, adenylcyclase, prostaglandin E1 synthesis, and inositol-1-phosphatase.
  • Lithium's activity on neutrophils and T lymphocytes contributes to its anti-inflammatory properties.

Purpose:

  • To investigate the efficacy and safety of topical lithium formulations for dermatological conditions.
  • To compare the effectiveness of topical lithium with oral lithium and other treatments like ketoconazole.
  • To evaluate the pharmacological actions and potential side effects of lithium in dermatological applications.

Summary:

  • Topical lithium, including lithium succinate and lithium gluconate, demonstrated efficacy in seborrheic dermatitis, outperforming placebo and showing non-inferiority to ketoconazole.

Related Experiment Videos

  • Oral lithium provided a reduction in herpes simplex symptom duration, but topical applications were found to be more effective overall.
  • Topical lithium exhibits good local safety with weak percutaneous penetration and minimal irritant side effects, unlike oral lithium which has frequent cutaneous side effects and teratogenicity concerns.

    • Impact:

    • Topical lithium formulations offer a potentially safer and effective alternative for managing seborrheic dermatitis and herpes simplex.
    • Understanding lithium's enzymatic and cellular activities can guide future dermatological drug development.
    • The findings support the use of topical lithium gluconate for seborrheic dermatitis, even in patients with renal insufficiency, with specific contraindications during early pregnancy.